In SLE study, we observed the significant increase of natural killer (NK) cells in response to Ld-IL2 treatment, which implicated potential augmentation of anti-infection cellular immunity.22 We also found that CD56bri NK cells were increased in association with Ld-IL2 administration (Supplementary Fig. 2). Here, IL2 is linked to infection.